GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) Trademark Information

SUN PHARMACEUTICAL INDUSTRIES LIMITED

medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and p...

medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine

Words that describe this mark

medicinal   pharmaceutical   preparations   packed   ready   use   infusion   bags   chemotherapy     reduction   tension   anxiety     improvement   heart   function     correction   hemodynamic   imbalances   present   shock   syndrome     blood  

This is a brand page for the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark by SUN PHARMACEUTICAL INDUSTRIES LIMITED  in Mumbai, Maharashtra, , 400063.

Write a review about a product or service associated with this GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark. Or, contact the owner SUN PHARMACEUTICAL INDUSTRIES LIMITED of the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark.

Status Update! On Tuesday, November 3, 2020, status on the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark changed to STATEMENT OF USE, REGISTRATION REVIEW COMPLETE.

On Thursday, September 20, 2018, a U.S. federal trademark registration was filed for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML). The USPTO has given the GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark serial number of 88125494. The current federal status of this trademark filing is STATEMENT OF USE, REGISTRATION REVIEW COMPLETE. The correspondent listed for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) is CRAIG KUCHII, ESQ. of SUN PHARMACEUTICAL INDUSTRIES, INC., INTELLECTUAL PROPERTY DEPT., 2 INDEPENDENCE WAY PRINCETON NJ 08540 . The GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark is filed in the category of Pharmaceutical Products , Medical Instrument Products . The description provided to the USPTO for GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) is medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine.

Word mark: GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML)
Status/Status Date:
STATEMENT OF USE, REGISTRATION REVIEW COMPLETE
11/3/2020
Serial Number: 88125494
Filing Date: 9/20/2018
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine
Mark Description: The mark consists of a green outline of a rectangle surrounding the word "GEMCITABINE" in black lettering above the words "in 0.9% sodium chloride injection" in black lettering, along with a green arched curve filling in the lower left hand corner, all of the foregoing above a smaller rectangle filled in green, with the words "1,600 mg per 160 mL (10 mg/mL)" in white letters. The color white in the rectangle with the arched curve represents background only and is not claimed as a feature of the mark.
Type Of Mark: TradeMark
Published For Opposition Date: 2/26/2019
Last Applicant/Owner: SUN PHARMACEUTICAL INDUSTRIES LIMITED
Mumbai, Maharashtra 400063
Mark Drawing Code: Drawing/Design + Words
Design Search:
Two rectangles (Geometric figures and solids - Rectangles) see more design...
Rectangles that are completely or partially shaded (Geometric figures and solids - Rectangles) see more design...
Curved line(s), band(s) or bar(s) (Geometric figures and solids - Lines, bands, bars, chevrons and angles) see more design...
Register Type: Principal
Disclaimer: ("GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML)")
Correspondent:
SUN PHARMACEUTICAL INDUSTRIES, INC.
INTELLECTUAL PROPERTY DEPT.
2 INDEPENDENCE WAY
PRINCETON NJ 08540

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided
Class (010)
Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $399/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
11/3/2020
STATEMENT OF USE, REGISTRATION REVIEW COMPLETE
Correspondent Search:

CRAIG KUCHII, ESQ. is a correspondent of GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,600 MG PER 160 ML (10 MG/ML) trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: